Single-Dose Anti-CD138 Radioimmunotherapy: Bismuth-213 is More Efficient than Lutetium-177 for Treatment of Multiple Myeloma in a Preclinical Model-Reference-Cited by-同舟云学术

Single-Dose Anti-CD138 Radioimmunotherapy: Bismuth-213 is More Efficient than Lutetium-177 for Treatment of Multiple Myeloma in a Preclinical Model

Published:2015-11-04 Issue: Volume:2 Page:
ISSN:2296-858X
Container-title:Frontiers in Medicine
language:
Short-container-title:Front. Med.

Author:

Fichou Nolwenn,Gouard Sébastien,Maurel Catherine,Barbet Jacques,Ferrer Ludovic,Morgenstern Alfred,Bruchertseifer Frank,Faivre-Chauvet Alain,Bigot-Corbel Edith,Davodeau François,Gaschet Joëlle,Chérel Michel

Funder

Commissariat Général à l’Investissement

European Commission

Publisher

Frontiers Media SA

Subject

General Medicine

Reference48 articles.

1. Multiple myeloma: clinical features and indications for therapy;Dispenzieri;Best Pract Res Clin Haematol,2005

2. International myeloma working group updated criteria for the diagnosis of multiple myeloma;Rajkumar;Lancet Oncol,2014

3. Shifts in the therapeutic paradigm for patients newly diagnosed with multiple myeloma: maintenance therapy and overall survival;Palumbo;Clin Cancer Res,2011

4. Frontline therapy of multiple myeloma;Moreau;Blood,2015

5. Responses to ionizing radiation mediated by inflammatory mechanisms;Mukherjee;J Pathol,2014

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in bismuth utilization for biomedical applications – From a bibliometric perspective;Coordination Chemistry Reviews;2024-10

2. Targeted therapy for multiple myeloma: an overview on CD138-based strategies;Frontiers in Oncology;2024-04-09

3. Preclinical Evaluation of a 64Cu-Based Theranostic Approach in a Murine Model of Multiple Myeloma;Pharmaceutics;2023-06-25

4. References;Radioactivity;2023

5. Biodistribution of 213Bi–Metallothionein and 213Bi–IgG in Intact Mice;Physics of Atomic Nuclei;2022-12